{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:56:24Z","timestamp":1784606184198,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Frontotemporal lobar degeneration (FTLD) is a clinical syndrome with pathological heterogeneity, including Pick\u2019s disease and trans-activating response region (TAR) DNA-binding protein with a molecular mass of 43 kDa (TDP-43) proteinopathy (FTLD-TDP). A previous study reported abnormal findings on dopamine transporter (DAT) imaging in 30% of patients with frontotemporal dementia (FTD) in FTLD. However, the previous study did not consider the pathological heterogeneity of FTD regarding the pathomechanism leading to abnormal DAT findings. Recently, abnormal DAT findings were reported in two patients with FTLD with motor neuron disease (MND), of which FTLD-TDP type B was the most common pathological presentation. This study investigated the DAT findings of patients with a final diagnosis of FTLD-MND to determine the frequency of occurrence of DAT abnormalities in FTLD-MND.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Twenty patients with FTLD who underwent DAT single photon emission computed tomography (DAT-SPECT) were screened, and six patients with a final diagnosis of FTLD-MND were ultimately included. The patients\u2019 DAT-SPECT findings were analyzed visually and quantitatively. Neuronal loss and astrogliosis in brain regions (substantia nigra, caudate, and putamen) that could possibly affect DAT findings were evaluated in the three pathologically confirmed cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>All six patients with FTLD-MND showed abnormal visual DAT-SPECT findings. In addition, in a quantitative assessment, the specific binding ratio in the striatum calculated by the Southampton method was below the lower limit of the 95% prediction interval of the healthy controls by age in all the present cases. Interestingly, three of the six patients showed abnormal findings on DAT-SPECT more than half a year before the onset of MND. Neuronal loss and astrogliosis in brain regions that may affect DAT findings were observed in three pathologically confirmed cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Dopamine transporter single photon emission computed tomography revealed abnormal findings in patients with FTLD-MND, which may manifest even before the onset of MND symptoms. We believe that the possibility of future development of MND should be considered if DAT-SPECT shows abnormal findings in FTLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2022.755211","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T08:53:25Z","timestamp":1645779205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Dopamine Transporter Imaging for Frontotemporal Lobar Degeneration With Motor Neuron Disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Ryota","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Kawakatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kanoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration.","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fneur.2015.00147","article-title":"Fronto-striatal atrophy in behavioral variant frontotemporal dementia and Alzheimer\u2019s disease.","volume":"6","author":"Bertoux","year":"2015","journal-title":"Front. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jnnp.65.2.263","article-title":"Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography.","volume":"65","author":"Borasio","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.arr.2015.12.009","article-title":"Molecular imaging of dopamine transporters.","volume":"30","author":"Brooks","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"The Lund and Manchester groups. Clinical and neuropathological criteria for frontotemporal dementia.","volume":"57","author":"Brun","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum.","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00415-019-09305-0","article-title":"Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.","volume":"266","author":"Calvo","year":"2019","journal-title":"J. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria.","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"20406223211044072","DOI":"10.1177\/20406223211044072","article-title":"The ipsilateral silent period: an early diagnostic marker of callosal disconnection in ALS.","volume":"12","author":"H\u00fcbers","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fneur.2020.00395","article-title":"Clinical and imaging markers of prodromal Parkinson\u2019s disease.","volume":"11","author":"Hustad","year":"2020","journal-title":"Front. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/neup.12364","article-title":"Typical and atypical appearance of early-onset Alzheimer\u2019s disease: a clinical, neuroimaging and neuropathological study.","volume":"37","author":"Kawakatsu","year":"2017","journal-title":"Neuropathology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/jnnp-2020-324266","article-title":"Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson\u2019s disease: a cross-sectional study.","volume":"92","author":"Kazmi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/psyg.12584","article-title":"Detection of reduced dopamine transporter availability by 123 I-N-omega-fluoropropyl-2-beta-carbomethoxy-3-beta (4-iodophenyl) nortropane single-photon emission computed tomography in a patient of frontotemporal dementia with motor neuron disease.","volume":"20","author":"Kobayashi","year":"2020","journal-title":"Psychogeriatrics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration.","volume":"70","author":"Lee","year":"2011","journal-title":"Ann. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1001\/jamaneurol.2020.2786","article-title":"Lost dopaminergic bindings in the caudate of a patient with frontotemporal lobar degeneration\u2013motor neuron disease.","volume":"77","author":"Liu","year":"2020","journal-title":"JAMA Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for FTLD-TDP pathology.","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00259-018-3976-5","article-title":"Japanese multicenter database of healthy controls for [123 I]FP-CIT SPECT.","volume":"45","author":"Matsuda","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1440-1789.2009.01059.x","article-title":"Clinical entity of frontotemporal dementia with motor neuron disease.","volume":"29","author":"Mitsuyama","year":"2009","journal-title":"Neuropathology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1136\/jnnp-2012-302577","article-title":"Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.","volume":"83","author":"Morgan","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/wnl.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0385-z","article-title":"Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions.","volume":"116","author":"Nishihira","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/cells8080872","article-title":"Molecular imaging of the dopamine transporter.","volume":"8","author":"Palermo","year":"2019","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.13001","article-title":"New perspective on parkinsonism in frontotemporal lobar degeneration.","volume":"6","author":"Park","year":"2013","journal-title":"J. Mov. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/mds.27816","article-title":"Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.","volume":"34","author":"Sakae","year":"2019","journal-title":"Mov. Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS.","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-140312","article-title":"Psychosis in frontotemporal dementia.","volume":"42","author":"Shinagawa","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fnins.2018.00473","article-title":"Pathogenesis of frontotemporal lobar degeneration: insights from loss of function theory and early involvement of the caudate nucleus.","volume":"12","author":"Sobue","year":"2018","journal-title":"Front. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.2169\/internalmedicine.0454-17","article-title":"Marked reduction in the striatal dopamine transporter uptake during the early stage of motor symptoms in patients with the MAPT N279K mutation.","volume":"57","author":"Takeshige","year":"2018","journal-title":"Intern. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","article-title":"Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio.","volume":"33","author":"Tossici-Bolt","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/JAD-170561","article-title":"11C-CFT-PET in presymptomatic FTDP-17: a potential biomarker predicting onset.","volume":"61","author":"Wu","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0022-510x(01)00671-2","article-title":"Preservation of nigral neurons in Pick\u2019s disease with Pick bodies: a clinicopathological and morphometric study of five autopsy cases.","volume":"194","author":"Yokota","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jnnp-2020-325944","article-title":"Factors predicting loss of independence and mortality in frontotemporal lobar degeneration.","volume":"92","author":"Yokota","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00401-009-0493-4","article-title":"Clinicopathological characterization of Pick\u2019s disease versus frontotemporal lobar degeneration with ubiquitin\/TDP-43-positive inclusions.","volume":"117","author":"Yokota","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00401-007-0285-7","article-title":"TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.","volume":"115","author":"Zhang","year":"2008","journal-title":"Acta Neuropathol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.755211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T08:53:27Z","timestamp":1645779207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.755211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":36,"alternative-id":["10.3389\/fnins.2022.755211"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.755211","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"755211"}}